DMCC Speciality Chemicals revenue up 35% in FY26 on higher realisations
DMCC Speciality Chemicals reported FY26 revenue of ₹581.58 crore, up 34.84% YoY, driven by higher sulphur prices in the bulk chemicals segment. PAT rose 26.95% to ₹27.33 crore, though EBITDA margins contracted to 11.04% from 13.49%. The Board proposed a ₹2.50 per share dividend and seeks approval to raise borrowing limits to ₹400 crore.

*this image is generated using AI for illustrative purposes only.
DMCC Speciality Chemicals reported consolidated revenue from operations of ₹581.58 crore for the financial year ended March 31, 2026 (FY26), marking a 34.84% increase over FY25. The growth was primarily driven by higher realisations in the bulk chemicals segment, where sustained rises in sulphur prices translated into elevated sulphuric acid pricing.
Profit after tax (PAT) rose 26.95% to ₹27.33 crore from ₹21.54 crore in the prior year. EBITDA increased by 10.23% to ₹64.33 crore. However, the consolidated EBITDA margin moderated to 11.04% from 13.49% in FY25, as the higher revenue base created by elevated commodity prices diluted percentage margins even as absolute profitability was protected.
Financial Performance
The company’s financial results reflect resilience amid global supply chain disruptions and geopolitical tensions affecting raw material availability.
| Metric: | FY26 | FY25 | Change |
|---|---|---|---|
| Revenue from Operations: | ₹581.58 crore | ₹431.29 crore | +34.84% |
| EBITDA: | ₹64.33 crore | ₹58.34 crore | +10.23% |
| EBITDA Margin: | 11.04% | 13.49% | -245 bps |
| Profit After Tax: | ₹27.33 crore | ₹21.54 crore | +26.95% |
Interest costs declined by 8.48% to ₹9.61 crore, although short-term borrowings rose in the second half of the year to fund higher working capital requirements.
Segment Review
The bulk chemicals segment was the principal driver of revenue growth, supported almost entirely by domestic demand. Tight global sulphur availability, compounded by disruptions to shipments through the Strait of Hormuz, drove prices to elevated levels. The company passed these higher input costs through to customers, protecting absolute profitability. Volumes held broadly steady, with the Dahej facility operating at normal levels while the Roha site faced temporary raw material constraints towards year-end.
In speciality chemicals, subdued demand in traditional European markets continued. The company expanded its presence in alternative geographies, recording improved offtake in Latin America, China, Japan, and Korea. Capacity utilisation in this segment continues to carry headroom, providing scope for scale-up as demand recovers.
The boron chemicals business experienced an uneven year due to a disruption in boron ore supply from Turkey in the first half. Supply was restored in the second half, allowing plants to run at full capacity with inventory rebuilt. Changes in procurement terms to advance payments added to the segment’s working capital requirement.
Dividend and AGM Details
The Board of Directors has recommended a final dividend of ₹2.50 per equity share of face value ₹10 each for FY26. This represents a 25% dividend yield on the face value. The record date for determining dividend eligibility is August 21, 2026. Payment will be made within 30 days of approval at the Annual General Meeting (AGM).
The 105th AGM is scheduled for September 11, 2026, to be conducted through Video Conferencing or Other Audio Visual Means (VC/OAVM). Key resolutions include:
- Adoption of audited standalone and consolidated financial statements for FY26.
- Reappointment of Mr. Kuldeep Tiwari as a director upon retirement by rotation.
- Ratification of remuneration of ₹1,00,000 plus taxes and expenses for S. S. Dongare as cost auditor for FY27.
- Approval for payment of commission to non-executive directors, capped at 1% of net profits computed under Section 198 of the Companies Act, 2013, for three years starting from FY27.
Borrowing Limit Enhancement
Shareholders will consider a special resolution to enhance borrowing powers from ₹200 crore to ₹400 crore. This authority allows the board to borrow funds exceeding the aggregate of paid-up share capital and free reserves for working capital requirements, acquisition of capital assets, and other corporate needs. Concurrently, shareholders will approve the creation of mortgages and charges on movable and immovable properties to secure these loans up to the same limit.
What the Numbers Show
The divergence between top-line growth and margin compression highlights the commodity-driven nature of DMCC’s current earnings profile. While revenue surged nearly 35%, EBITDA grew only 10%, indicating that volume growth was minimal and gains were purely price-led. Furthermore, the rise in short-term borrowings alongside stable interest costs suggests efficient debt management, but the increasing working capital requirement in the boron segment signals potential liquidity pressure if procurement terms remain unchanged.
Historical Stock Returns for DMCC Speciality Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.01% | -8.10% | +8.48% | +20.37% | -12.87% | -5.95% |
How sustainable is the current pricing power for sulphuric acid if global sulphur supply chains normalize post-Strait of Hormuz disruptions?
Will the doubling of borrowing limits to ₹400 crore signal specific upcoming capital expenditures or acquisitions in the specialty chemicals segment?
Can DMCC leverage its excess capacity in specialty chemicals to offset continued demand weakness in European markets with faster growth in Asia and Latin America?


































